ADVANCED OR METASTATIC MTAP-DELETED SOLID TUMORS

Clinical trials for ADVANCED OR METASTATIC MTAP-DELETED SOLID TUMORS explained in plain language.

Never miss a new study

Get alerted when new ADVANCED OR METASTATIC MTAP-DELETED SOLID TUMORS trials appear

Sign up with your email to follow new studies for ADVANCED OR METASTATIC MTAP-DELETED SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

First patients test promising new cancer pill targeting specific genetic flaw

Disease control Ongoing

This is the first study in people testing a new oral drug called BG-89894 for advanced solid tumors that have a specific genetic change (MTAP deletion). The main goals are to find a safe dose, see how the body processes the drug, and look for early signs that it might help contro…

Matched conditions: ADVANCED OR METASTATIC MTAP-DELETED SOLID TUMORS

Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control

Last updated Apr 02, 2026 02:26 UTC

ADVANCED OR METASTATIC MTAP-DELETED SOLID TUMORS

Get alerted when new ADVANCED OR METASTATIC MTAP-DELETED SOLID TUMORS trials appear

First patients test promising new cancer pill targeting specific genetic flaw